Factors Affecting the Difficulty of Laparoscopic D2 Lymph Node Dissection for Gastric Cancer
1 other identifier
observational
187
1 country
1
Brief Summary
Laparoscopic D2 lymph node dissection (LND) for gastric cancer has a wide range of operations and a high degree of difficulty.The purpose of this study was to evaluate the relationship between clinicopathological factors and the difficulty of laparoscopic D2 LND.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2022
CompletedFirst Submitted
Initial submission to the registry
October 15, 2022
CompletedFirst Posted
Study publicly available on registry
October 18, 2022
CompletedOctober 18, 2022
October 1, 2022
4 months
October 15, 2022
October 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
surgery complicated
Incidence of operative complications between qualified group and unqualified group
30 days after operation
Study Arms (2)
qualified of D2 Lymph node dissection group
not-qualified D2 Lymph node dissection group
Interventions
Klass-02-QC LND scale and general error score tool were used to quantitatively evaluate the intraoperative performance of D2 LND
Eligibility Criteria
The CLASS-01 trial is a prospective multicenter randomized controlled study (ClinicalTrials.gov.number:NCT01609309) to compare the oncological efficacy of laparoscopy and laparotomy in the treatment of locally advanced distal gastric cancer. In this study, 119 patients who underwent laparoscopic surgery at our center who participated in CLASS-01 were selected. All the patients were operated with 2D laparoscopic system.The 2D/3D trial is a prospective clinical trial (ClinicalTrials.gov.number:NCT02327481) that compares the curative effect of 2D and 3D laparoscopic radical gastrectomy in our center. Seventy cases of 2D laparoscopic distal gastrectomy (LDG) were selected
You may qualify if:
- all patients undergoing laparoscopic surgery
- Laparoscopic system is 2D and has complete D2 lymph node dissection.
You may not qualify if:
- patients undergoing laparotomy
- incomplete video or clinicopathological information
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastric Surgery
Fuzhou, Fujian, China
Related Publications (1)
Lu J, Huang JB, Wu D, Xie JW, Wang JB, Lin JX, Zheng CH, Huang CM, Li P. Factors affecting the quality of laparoscopic D2 lymph node dissection for gastric cancer: a cohort study from two randomized controlled trials. Int J Surg. 2023 May 1;109(5):1249-1256. doi: 10.1097/JS9.0000000000000290.
PMID: 37026819DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
October 15, 2022
First Posted
October 18, 2022
Study Start
January 1, 2022
Primary Completion
May 10, 2022
Study Completion
June 20, 2022
Last Updated
October 18, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share